ALKS |
Alkermes plc. |
Feb 23, 2024 |
5 |
-$101K |
4 |
Feb 27, 2024 |
EVP R&D, Chief Medical Officer |
ALKS |
Alkermes plc. |
Feb 22, 2024 |
3 |
-$158K |
4 |
Feb 23, 2024 |
EVP R&D, Chief Medical Officer |
ALKS |
Alkermes plc. |
Feb 18, 2024 |
6 |
-$266K |
4 |
Feb 21, 2024 |
EVP R&D, Chief Medical Officer |
ALKS |
Alkermes plc. |
Feb 8, 2024 |
13 |
$101K |
4 |
Feb 12, 2024 |
EVP R&D, Chief Medical Officer |
ALBO |
ALBIREO PHARMA, INC. |
Mar 2, 2023 |
1 |
$0 |
4 |
Mar 2, 2023 |
Director |
ALKS |
Alkermes plc. |
Feb 22, 2023 |
5 |
-$148K |
4 |
Feb 24, 2023 |
EVP R&D, Chief Medical Officer |
ALKS |
Alkermes plc. |
Feb 18, 2023 |
11 |
-$449K |
4 |
Feb 22, 2023 |
EVP R&D, Chief Medical Officer |
ALBO |
ALBIREO PHARMA, INC. |
Dec 1, 2022 |
0 |
$0 |
3 |
Dec 5, 2022 |
Director |
ALBO |
ALBIREO PHARMA, INC. |
Dec 1, 2022 |
1 |
$0 |
4 |
Dec 5, 2022 |
Director |
ALKS |
Alkermes plc. |
Feb 23, 2022 |
1 |
-$297K |
4 |
Feb 24, 2022 |
EVP R&D, Chief Medical Officer |
ALKS |
Alkermes plc. |
Feb 18, 2022 |
12 |
-$272K |
4 |
Feb 23, 2022 |
EVP R&D, Chief Medical Officer |
ALKS |
Alkermes plc. |
Feb 16, 2022 |
3 |
-$28.6K |
4 |
Feb 17, 2022 |
EVP R&D, Chief Medical Officer |
ALKS |
Alkermes plc. |
Sep 14, 2021 |
2 |
-$173K |
4 |
Sep 16, 2021 |
EVP R&D, Chief Medical Officer |
ALKS |
Alkermes plc. |
Jun 9, 2021 |
1 |
-$21.7K |
4 |
Jun 11, 2021 |
EVP R&D, Chief Medical Officer |
ALKS |
Alkermes plc. |
Jun 7, 2021 |
3 |
-$8.65K |
4 |
Jun 8, 2021 |
EVP R&D, Chief Medical Officer |